Oric Pharmaceuticals Inc (ORIC)

ORIC Pharmaceuticals' (ORIC) “Overweight” Rating Reaffirmed at Cantor Fitzgerald - Defense World

Defense World

ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Up 3.2% - Defense World

Defense World

ORIC Pharmaceuticals Inc: Navigating Market Fluctuations with a 484.08M Market Cap - The InvestChronicle

The InvestChronicle

Ratios Reveal: Breaking Down ORIC Pharmaceuticals Inc (ORIC)'s Financial Health – DWinneX - The Dwinnex

The Dwinnex

Companies Like ORIC Pharmaceuticals (NASDAQ:ORIC) Are In A Position To Invest In Growth - Yahoo New Zealand News

Yahoo New Zealand News

Stock Market Recap: ORIC Pharmaceuticals Inc (ORIC) Concludes at 7.68, a -2.78 Surge/Decline – DWinneX - The Dwinnex

The Dwinnex

What is the investor’s view on ORIC Pharmaceuticals Inc (ORIC)? - US Post News

US Post News

ORIC Pharmaceuticals (NASDAQ:ORIC) Trading Down 4.9% - MarketBeat

MarketBeat

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

GlobeNewswire

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire Inc.

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

GlobeNewswire

When (ORIC) Moves Investors should Listen - Stock Traders Daily

Stock Traders Daily

Brokerages Set ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Price Target at $20.00 - MarketBeat

MarketBeat

ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Gap Up to $8.45 - Defense World

Defense World

ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Receives Average Recommendation of “Buy” from Analysts - Defense World

Defense World

Corient Private Wealth LLC Acquires New Holdings in Columbia Emerging Markets Consumer ETF (NYSEARCA:ECON) - Defense World

Defense World

ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Gap Up to $8.45 - MarketBeat

MarketBeat

ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Gap Up to $8.45 - MarketBeat

MarketBeat

ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewswire

GlobeNewswire

ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences - Yahoo Finance

Yahoo Finance

ORIC Pharmaceuticals (NASDAQ:ORIC) Given “Overweight” Rating at Cantor Fitzgerald - Defense World

Defense World

ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences - Yahoo Finance

Yahoo Finance

Cantor Fitzgerald Reiterates Overweight Rating for ORIC Pharmaceuticals (NASDAQ:ORIC) - MarketBeat

MarketBeat

ORIC Pharmaceuticals Inc (ORIC) rating initates by Cantor Fitzgerald – Knox Daily - Knox Daily

Knox Daily

Cantor Fitzgerald Reiterates Overweight Rating for ORIC Pharmaceuticals (NASDAQ:ORIC) - MarketBeat

MarketBeat

Blueprint Medicines' (BPMC) Ayvakit Meets Goal in PIONEER Study - Yahoo Movies UK

Yahoo Movies UK

(ORIC) Investment Analysis - Stock Traders Daily

Stock Traders Daily

ORIC Pharmaceuticals Inc (ORIC) may enjoy gains as insiders got busy in the recent days – Knox Daily - Knox Daily

Knox Daily

New York State Common Retirement Fund Sells 6131 Shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - Defense World

Defense World

ORIC Pharmaceuticals (NASDAQ:ORIC) Stock Price Up 5.5% - MarketBeat

MarketBeat

These Are the Most Heavily Shorted Stocks Heating Up the Market - 24/7 Wall St.

24/7 Wall St.

HC Wainwright Analysts Increase Earnings Estimates for ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - MarketBeat

MarketBeat

ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Shares Purchased by M&T Bank Corp - Defense World

Defense World

(ORIC) Trading Advice - Stock Traders Daily

Stock Traders Daily

HC Wainwright Analysts Increase Earnings Estimates for ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - MarketBeat

MarketBeat

ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) to Post Q2 2024 Earnings of ($0.42) Per Share, HC Wainwright Forecasts - Defense World

Defense World

Monaco Asset Management SAM Sells 104,793 Shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - MarketBeat

MarketBeat

Avidity Biosciences (RNA) Stock Forecast and Price Target 2024 - MarketBeat

MarketBeat

ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) to Post Q1 2025 Earnings of ($0.47) Per Share, HC Wainwright Forecasts - Defense World

Defense World

Monaco Asset Management SAM Sells 104,793 Shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - MarketBeat

MarketBeat

ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Gap Up to $9.50 - MarketBeat

MarketBeat

Q1 2025 Earnings Estimate for ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Issued By HC Wainwright - MarketBeat

MarketBeat

ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Gap Up to $9.50 - MarketBeat

MarketBeat

Wedbush Equities Analysts Raise Earnings Estimates for ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - MarketBeat

MarketBeat

ORIC Pharmaceuticals (NASDAQ:ORIC) PT Lowered to $14.00 - Defense World

Defense World

Wedbush Equities Analysts Raise Earnings Estimates for ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - MarketBeat

MarketBeat

Cantor Fitzgerald analysts initates an Overweight rating for ORIC Pharmaceuticals Inc (ORIC) – Knox Daily - Knox Daily

Knox Daily

We're Hopeful That ORIC Pharmaceuticals (NASDAQ:ORIC) Will Use Its Cash Wisely - Simply Wall St

Simply Wall St

We Think ORIC Pharmaceuticals (NASDAQ:ORIC) Can Afford To Drive Business Growth - Yahoo Finance

Yahoo Finance

We're Hopeful That ORIC Pharmaceuticals (NASDAQ:ORIC) Will Use Its Cash Wisely - Simply Wall St

Simply Wall St